ArticleOncogene2026

KAT5-mediated HSPA1A lactylation drives immunotherapy resistance by inhibiting STAT1 degradation in esophageal squamous cell carcinoma.

Ziyi Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.